{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T18:43:56Z","timestamp":1785005036654,"version":"3.55.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["284\/19"],"award-info":[{"award-number":["284\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["284\/19"],"award-info":[{"award-number":["284\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["284\/19"],"award-info":[{"award-number":["284\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["284\/19"],"award-info":[{"award-number":["284\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["284\/19"],"award-info":[{"award-number":["284\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by loss of upper and lower motor neurons. About 20% of familial ALS cases are caused by dominant mutations in SOD1. It has been suggested that toxicity of mutant SOD1 results from its misfolding, however, it is unclear why misfolded SOD1 accumulates within specific tissues. We have demonstrated that macrophage migration inhibitory factor (MIF), a multifunctional protein with cytokine\/chemokine and chaperone-like activity, inhibits the accumulation and aggregation of misfolded SOD1. Although MIF homolog, D-dopachrome tautomerase (D-DT\/MIF-2), shares structural and genetic similarities with MIF, its biological function is not well understood. In the current study, we investigated, for the first time, the mechanism of action of D-DT in a model of ALS. We show that D-DT inhibits mutant SOD1 amyloid aggregation in vitro, promoting the formation of amorphous aggregates. Moreover, we report that D-DT interacts with mutant SOD1, but does not inhibit misfolded mutant SOD1 accumulation and toxicity in neuronal cells. Finally, we show that D-DT is expressed mainly in liver and kidney, with extremely low expression in brain and spinal cord of adult mice. Our findings contribute to better understanding of D-DT versus MIF function in the context of ALS.<\/jats:p>","DOI":"10.1038\/s41598-022-13744-7","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T10:05:00Z","timestamp":1654855500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["MIF homolog d-dopachrome tautomerase (D-DT\/MIF-2) does not inhibit accumulation and toxicity of misfolded SOD1"],"prefix":"10.1038","volume":"12","author":[{"given":"Amina","family":"Alaskarov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shir","family":"Barel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamchal","family":"Bakavayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Israelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"13744_CR1","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","volume":"344","author":"LP Rowland","year":"2001","unstructured":"Rowland, L. P. & Shneider, N. A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 344, 1688\u20131700. https:\/\/doi.org\/10.1056\/NEJM200105313442207 (2001).","journal-title":"N. Engl. J. Med."},{"key":"13744_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chio","year":"2009","unstructured":"Chio, A. et al. Prognostic factors in ALS: A critical review. Amyotroph. Lateral Scler 10, 310\u2013323. https:\/\/doi.org\/10.3109\/17482960802566824 (2009).","journal-title":"Amyotroph. Lateral Scler"},{"key":"13744_CR3","doi-asserted-by":"publisher","unstructured":"Petrov, D., Mansfield, C., Moussy, A. & Hermine, O. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front. Aging Neurosci. 9, 68, doi:https:\/\/doi.org\/10.3389\/fnagi.2017.00068 (2017).","DOI":"10.3389\/fnagi.2017.00068"},{"key":"13744_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/14656566.2017.1319937","volume":"18","author":"H Sawada","year":"2017","unstructured":"Sawada, H. Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Exp. Opin. Pharmacother. 18, 735\u2013738. https:\/\/doi.org\/10.1080\/14656566.2017.1319937 (2017).","journal-title":"Exp. Opin. Pharmacother."},{"key":"13744_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1326-8-28","volume":"8","author":"S Chen","year":"2013","unstructured":"Chen, S., Sayana, P., Zhang, X. & Le, W. Genetics of amyotrophic lateral sclerosis: an update. Mol. Neurodegen. 8, 28. https:\/\/doi.org\/10.1186\/1750-1326-8-28 (2013).","journal-title":"Mol. Neurodegen."},{"key":"13744_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/DNND.S84956","volume":"6","author":"AA Alsultan","year":"2016","unstructured":"Alsultan, A. A., Waller, R., Heath, P. R. & Kirby, J. The genetics of amyotrophic lateral sclerosis: Current insights. Degen. Neurol. Neuromuscul. Dis. 6, 49\u201364. https:\/\/doi.org\/10.2147\/DNND.S84956 (2016).","journal-title":"Degen. Neurol. Neuromuscul. Dis."},{"key":"13744_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/19491034.2016.1172152","volume":"7","author":"K Zhang","year":"2016","unstructured":"Zhang, K., Grima, J. C., Rothstein, J. D. & Lloyd, T. E. Nucleocytoplasmic transport in C9orf72-mediated ALS\/FTD. Nucleus 7, 132\u2013137. https:\/\/doi.org\/10.1080\/19491034.2016.1172152 (2016).","journal-title":"Nucleus"},{"key":"13744_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.scr.2018.06.005","volume":"30","author":"J Higelin","year":"2018","unstructured":"Higelin, J. et al. NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res. 30, 150\u2013162. https:\/\/doi.org\/10.1016\/j.scr.2018.06.005 (2018).","journal-title":"Stem Cell Res."},{"key":"13744_CR9","doi-asserted-by":"publisher","first-page":"10465","DOI":"10.1038\/ncomms10465","volume":"7","author":"A Sharma","year":"2016","unstructured":"Sharma, A. et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 7, 10465. https:\/\/doi.org\/10.1038\/ncomms10465 (2016).","journal-title":"Nat. Commun."},{"key":"13744_CR10","doi-asserted-by":"publisher","first-page":"47551","DOI":"10.1074\/jbc.M207356200","volume":"277","author":"R Rakhit","year":"2002","unstructured":"Rakhit, R. et al. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 277, 47551\u201347556. https:\/\/doi.org\/10.1074\/jbc.M207356200 (2002).","journal-title":"J. Biol. Chem."},{"key":"13744_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D. R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59\u201362. https:\/\/doi.org\/10.1038\/362059a0 (1993).","journal-title":"Nature"},{"key":"13744_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","volume":"88","author":"ZY Zou","year":"2017","unstructured":"Zou, Z. Y. et al. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 88, 540\u2013549. https:\/\/doi.org\/10.1136\/jnnp-2016-315018 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"13744_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1159\/000131014","volume":"22","author":"T Philip","year":"1978","unstructured":"Philip, T. et al. Confirmation of the assignment of the human SODS gene to chromosome 21q22. Cytogenet. Cell Genet. 22, 521\u2013523. https:\/\/doi.org\/10.1159\/000131014 (1978).","journal-title":"Cytogenet. Cell Genet."},{"key":"13744_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jbior.2015.10.006","volume":"60","author":"Y Hayashi","year":"2016","unstructured":"Hayashi, Y., Homma, K. & Ichijo, H. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv. Biol. Regul. 60, 95\u2013104. https:\/\/doi.org\/10.1016\/j.jbior.2015.10.006 (2016).","journal-title":"Adv. Biol. Regul."},{"key":"13744_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/B978-0-12-385883-2.00002-3","volume":"107","author":"RL Redler","year":"2012","unstructured":"Redler, R. L. & Dokholyan, N. V. The complex molecular biology of amyotrophic lateral sclerosis (ALS). Prog. Mol. Biol. Trans. Sci. 107, 215\u2013262. https:\/\/doi.org\/10.1016\/B978-0-12-385883-2.00002-3 (2012).","journal-title":"Prog. Mol. Biol. Trans. Sci."},{"key":"13744_CR16","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1093\/hmg\/ddi297","volume":"14","author":"J Zhai","year":"2005","unstructured":"Zhai, J., Lin, H., Canete-Soler, R. & Schlaepfer, W. W. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS. Hum. Mol. Genet. 14, 2629\u20132640. https:\/\/doi.org\/10.1093\/hmg\/ddi297 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"13744_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.neuron.2010.07.019","volume":"67","author":"A Israelson","year":"2010","unstructured":"Israelson, A. et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 67, 575\u2013587 (2010).","journal-title":"Neuron"},{"key":"13744_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1042\/BJ20061202","volume":"405","author":"A Agbas","year":"2007","unstructured":"Agbas, A. et al. Activation of brain calcineurin (Cn) by Cu-Zn superoxide dismutase (SOD1) depends on direct SOD1-Cn protein interactions occurring in vitro and in vivo. Biochem. J. 405, 51\u201359. https:\/\/doi.org\/10.1042\/BJ20061202 (2007).","journal-title":"Biochem. J."},{"key":"13744_CR19","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1021\/acschemneuro.7b00140","volume":"8","author":"S Abu-Hamad","year":"2017","unstructured":"Abu-Hamad, S., Kahn, J., Leyton-Jaimes, M. F., Rosenblatt, J. & Israelson, A. Misfolded SOD1 accumulation and mitochondrial association contribute to the selective vulnerability of motor neurons in familial ALS: Correlation to human disease. ACS Chem. Neurosci. 8, 2225\u20132234. https:\/\/doi.org\/10.1021\/acschemneuro.7b00140 (2017).","journal-title":"ACS Chem. Neurosci."},{"key":"13744_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fncel.2019.00346","volume":"13","author":"A Shteinfer-Kuzmine","year":"2019","unstructured":"Shteinfer-Kuzmine, A. et al. A VDAC1-derived N-terminal peptide inhibits mutant SOD1-VDAC1 interactions and toxicity in the SOD1 model of ALS. Front. Cell Neurosci. 13, 346. https:\/\/doi.org\/10.3389\/fncel.2019.00346 (2019).","journal-title":"Front. Cell Neurosci."},{"key":"13744_CR21","doi-asserted-by":"publisher","first-page":"21146","DOI":"10.1073\/pnas.1014862107","volume":"107","author":"Q Li","year":"2010","unstructured":"Li, Q. et al. ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc. Natl. Acad. Sci. USA 107, 21146\u201321151 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"13744_CR22","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1101\/gad.1640108","volume":"22","author":"H Nishitoh","year":"2008","unstructured":"Nishitoh, H. et al. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22, 1451\u20131464. https:\/\/doi.org\/10.1101\/gad.1640108 (2008).","journal-title":"Genes Dev."},{"key":"13744_CR23","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/nn.2660","volume":"13","author":"DA Bosco","year":"2010","unstructured":"Bosco, D. A. et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 13, 1396\u20131403 (2010).","journal-title":"Nat. Neurosci."},{"key":"13744_CR24","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1073\/pnas.1115402109","volume":"109","author":"S Guareschi","year":"2012","unstructured":"Guareschi, S. et al. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc. Natl. Acad. Sci. USA 109, 5074\u20135079. https:\/\/doi.org\/10.1073\/pnas.1115402109 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"13744_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ana.21319","volume":"62","author":"E Kabashi","year":"2007","unstructured":"Kabashi, E., Valdmanis, P. N., Dion, P. & Rouleau, G. A. Oxidized\/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?. Ann. Neurol. 62, 553\u2013559. https:\/\/doi.org\/10.1002\/ana.21319 (2007).","journal-title":"Ann. Neurol."},{"key":"13744_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00401-011-0805-3","volume":"121","author":"K Forsberg","year":"2011","unstructured":"Forsberg, K., Andersen, P. M., Marklund, S. L. & Brannstrom, T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol. 121, 623\u2013634 (2011).","journal-title":"Acta Neuropathol."},{"key":"13744_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011552","volume":"5","author":"K Forsberg","year":"2010","unstructured":"Forsberg, K. et al. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS ONE 5, e11552 (2010).","journal-title":"PLoS ONE"},{"key":"13744_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1471-4159.2011.07177.x","volume":"117","author":"P Zetterstrom","year":"2011","unstructured":"Zetterstrom, P., Andersen, P. M., Brannstrom, T. & Marklund, S. L. Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients. J. Neurochem. 117, 91\u201399. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07177.x (2011).","journal-title":"J. Neurochem."},{"key":"13744_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4161\/pri.27602","volume":"8","author":"LI Grad","year":"2014","unstructured":"Grad, L. I. & Cashman, N. R. Prion-like activity of Cu\/Zn superoxide dismutase: implications for amyotrophic lateral sclerosis. Prion 8, 33\u201341 (2014).","journal-title":"Prion"},{"key":"13744_CR30","doi-asserted-by":"publisher","first-page":"14223","DOI":"10.1038\/s41598-018-31773-z","volume":"8","author":"B Pare","year":"2018","unstructured":"Pare, B. et al. Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci. Rep. 8, 14223. https:\/\/doi.org\/10.1038\/s41598-018-31773-z (2018).","journal-title":"Sci. Rep."},{"key":"13744_CR31","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1093\/hmg\/ddq408","volume":"19","author":"M Prudencio","year":"2010","unstructured":"Prudencio, M., Durazo, A., Whitelegge, J. P. & Borchelt, D. R. An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Hum. Mol. Genet. 19, 4774\u20134789. https:\/\/doi.org\/10.1093\/hmg\/ddq408 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"13744_CR32","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00401-014-1342-7","volume":"128","author":"JI Ayers","year":"2014","unstructured":"Ayers, J. I. et al. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol. 128, 791\u2013803. https:\/\/doi.org\/10.1007\/s00401-014-1342-7 (2014).","journal-title":"Acta Neuropathol."},{"key":"13744_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00401-010-0646-5","volume":"119","author":"A Kerman","year":"2010","unstructured":"Kerman, A. et al. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathol. 119, 335\u2013344. https:\/\/doi.org\/10.1007\/s00401-010-0646-5 (2010).","journal-title":"Acta Neuropathol."},{"key":"13744_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ana.21704","volume":"66","author":"HN Liu","year":"2009","unstructured":"Liu, H. N. et al. Lack of evidence of monomer\/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 66, 75\u201380. https:\/\/doi.org\/10.1002\/ana.21704 (2009).","journal-title":"Ann. Neurol."},{"key":"13744_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-017-1688-8","volume":"134","author":"S Da Cruz","year":"2017","unstructured":"Da Cruz, S. et al. Misfolded SOD1 is not a primary component of sporadic ALS. Acta Neuropathol. 134, 97\u2013111. https:\/\/doi.org\/10.1007\/s00401-017-1688-8 (2017).","journal-title":"Acta Neuropathol."},{"key":"13744_CR36","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1093\/hmg\/ddt249","volume":"22","author":"S Pickles","year":"2013","unstructured":"Pickles, S. et al. Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1. Hum. Mol. Genet. 22, 3947\u20133959. https:\/\/doi.org\/10.1093\/hmg\/ddt249 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"13744_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12017-012-8204-z","volume":"15","author":"P Zetterstrom","year":"2013","unstructured":"Zetterstrom, P., Graffmo, K. S., Andersen, P. M., Brannstrom, T. & Marklund, S. L. Composition of soluble misfolded superoxide dismutase-1 in murine models of amyotrophic lateral sclerosis. Neuromol. Med. 15, 147\u2013158. https:\/\/doi.org\/10.1007\/s12017-012-8204-z (2013).","journal-title":"Neuromol. Med."},{"key":"13744_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.expneurol.2017.06.021","volume":"301","author":"MF Leyton-Jaimes","year":"2018","unstructured":"Leyton-Jaimes, M. F., Kahn, J. & Israelson, A. Macrophage migration inhibitory factor: A multifaceted cytokine implicated in multiple neurological diseases. Exp. Neurol. 301, 83\u201391. https:\/\/doi.org\/10.1016\/j.expneurol.2017.06.021 (2018).","journal-title":"Exp. Neurol."},{"key":"13744_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuron.2015.02.034","volume":"86","author":"A Israelson","year":"2015","unstructured":"Israelson, A. et al. Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1. Neuron 86, 218\u2013232. https:\/\/doi.org\/10.1016\/j.neuron.2015.02.034 (2015).","journal-title":"Neuron"},{"key":"13744_CR40","doi-asserted-by":"publisher","first-page":"10198","DOI":"10.1073\/pnas.1604600113","volume":"113","author":"MF Leyton-Jaimes","year":"2016","unstructured":"Leyton-Jaimes, M. F. et al. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS. Proc. Natl. Acad Sci. USA 113, 10198\u201310203. https:\/\/doi.org\/10.1073\/pnas.1604600113 (2016).","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"13744_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41419-017-0130-4","volume":"9","author":"N Shvil","year":"2018","unstructured":"Shvil, N. et al. MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS. Cell Death Dis. 9, 107. https:\/\/doi.org\/10.1038\/s41419-017-0130-4 (2018).","journal-title":"Cell Death Dis."},{"key":"13744_CR42","doi-asserted-by":"publisher","first-page":"14755","DOI":"10.1073\/pnas.1904665116","volume":"116","author":"MF Leyton-Jaimes","year":"2019","unstructured":"Leyton-Jaimes, M. F., Kahn, J. & Israelson, A. AAV2\/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS. Proc. Natl. Acad Sci. USA 116, 14755\u201314760. https:\/\/doi.org\/10.1073\/pnas.1904665116 (2019).","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"13744_CR43","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1038\/sj.onc.1207490","volume":"23","author":"Y Ren","year":"2004","unstructured":"Ren, Y. et al. Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene 23, 4146\u20134154. https:\/\/doi.org\/10.1038\/sj.onc.1207490 (2004).","journal-title":"Oncogene"},{"key":"13744_CR44","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1182\/blood.2020005795","volume":"136","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma. Blood 136, 2557\u20132573. https:\/\/doi.org\/10.1182\/blood.2020005795 (2020).","journal-title":"Blood"},{"key":"13744_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cyto.2012.03.014","volume":"59","author":"M Merk","year":"2012","unstructured":"Merk, M., Mitchell, R. A., Endres, S. & Bucala, R. D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family. Cytokine 59, 10\u201317. https:\/\/doi.org\/10.1016\/j.cyto.2012.03.014 (2012).","journal-title":"Cytokine"},{"key":"13744_CR46","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/s0167-4838(98)00214-3","volume":"1388","author":"T Kuriyama","year":"1998","unstructured":"Kuriyama, T., Fujinaga, M., Koda, T. & Nishihira, J. Cloning of the mouse gene for D-dopachrome tautomerase. Biochim Biophys. Acta 1388, 506\u2013512. https:\/\/doi.org\/10.1016\/s0167-4838(98)00214-3 (1998).","journal-title":"Biochim Biophys. Acta"},{"key":"13744_CR47","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1006\/bbrc.1998.8123","volume":"243","author":"J Nishihira","year":"1998","unstructured":"Nishihira, J. et al. Molecular cloning of human D-dopachrome tautomerase cDNA: N-terminal proline is essential for enzyme activation. Biochem. Biophys. Res. Commun. 243, 538\u2013544. https:\/\/doi.org\/10.1006\/bbrc.1998.8123 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"13744_CR48","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0014-5793(95)01041-c","volume":"373","author":"M Zhang","year":"1995","unstructured":"Zhang, M. et al. Cloning and sequencing of a cDNA encoding rat D-dopachrome tautomerase. FEBS Lett. 373, 203\u2013206. https:\/\/doi.org\/10.1016\/0014-5793(95)01041-c (1995).","journal-title":"FEBS Lett."},{"key":"13744_CR49","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1600-0609.1996.tb01372.x","volume":"57","author":"P Bjork","year":"1996","unstructured":"Bjork, P. et al. A new enzyme activity in human blood cells and isolation of the responsible protein (D-dopachrome tautomerase) from erythrocytes. Eur. J. Haematol. 57, 254\u2013256. https:\/\/doi.org\/10.1111\/j.1600-0609.1996.tb01372.x (1996).","journal-title":"Eur. J. Haematol."},{"key":"13744_CR50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF03402210","volume":"2","author":"E Rosengren","year":"1996","unstructured":"Rosengren, E. et al. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol. Med. 2, 143\u2013149 (1996).","journal-title":"Mol. Med."},{"key":"13744_CR51","doi-asserted-by":"publisher","first-page":"E577","DOI":"10.1073\/pnas.1102941108","volume":"108","author":"M Merk","year":"2011","unstructured":"Merk, M. et al. The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). Proc. Natl. Acad Sci. USA 108, E577-585. https:\/\/doi.org\/10.1073\/pnas.1102941108 (2011).","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"13744_CR52","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu Zn superoxide dismutase mutation. Science 264, 1772\u20131775. https:\/\/doi.org\/10.1126\/science.8209258 (1994).","journal-title":"Science"},{"key":"13744_CR53","doi-asserted-by":"publisher","first-page":"24167","DOI":"10.1074\/jbc.M802083200","volume":"283","author":"Y Furukawa","year":"2008","unstructured":"Furukawa, Y., Kaneko, K., Yamanaka, K., O\u2019Halloran, T. V. & Nukina, N. Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J. Biol. Chem. 283, 24167\u201324176. https:\/\/doi.org\/10.1074\/jbc.M802083200 (2008).","journal-title":"J. Biol. Chem."},{"key":"13744_CR54","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/s0076-6879(99)09020-5","volume":"309","author":"H LeVine 3rd","year":"1999","unstructured":"LeVine, H. 3rd. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309, 274\u2013284. https:\/\/doi.org\/10.1016\/s0076-6879(99)09020-5 (1999).","journal-title":"Methods Enzymol."},{"key":"13744_CR55","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.bbrc.2006.02.170","volume":"343","author":"S Koyama","year":"2006","unstructured":"Koyama, S. et al. Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70. Biochem. Biophys. Res. Commun. 343, 719\u2013730. https:\/\/doi.org\/10.1016\/j.bbrc.2006.02.170 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"13744_CR56","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s003359900858","volume":"9","author":"N Esumi","year":"1998","unstructured":"Esumi, N. et al. Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIF. Mamm Genome 9, 753\u2013757. https:\/\/doi.org\/10.1007\/s003359900858 (1998).","journal-title":"Mamm Genome"},{"key":"13744_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","volume":"57","author":"SS Jankauskas","year":"2019","unstructured":"Jankauskas, S. S., Wong, D. W. L., Bucala, R., Djudjaj, S. & Boor, P. Evolving complexity of MIF signaling. Cell Signal 57, 76\u201388. https:\/\/doi.org\/10.1016\/j.cellsig.2019.01.006 (2019).","journal-title":"Cell Signal"},{"key":"13744_CR58","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.drudis.2018.11.003","volume":"24","author":"S Gunther","year":"2019","unstructured":"Gunther, S. et al. Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets. Drug Discov. Today 24, 428\u2013439. https:\/\/doi.org\/10.1016\/j.drudis.2018.11.003 (2019).","journal-title":"Drug Discov. Today"},{"key":"13744_CR59","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/s-0039-1677803","volume":"119","author":"D Sinitski","year":"2019","unstructured":"Sinitski, D. et al. Macrophage migration inhibitory factor (MIF)-Based therapeutic concepts in atherosclerosis and inflammation. Thromb. Haemost. 119, 553\u2013566. https:\/\/doi.org\/10.1055\/s-0039-1677803 (2019).","journal-title":"Thromb. Haemost."},{"key":"13744_CR60","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.3892\/ol.2018.8990","volume":"16","author":"M Presti","year":"2018","unstructured":"Presti, M. et al. Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma. Oncol. Lett. 16, 2881\u20132886. https:\/\/doi.org\/10.3892\/ol.2018.8990 (2018).","journal-title":"Oncol. Lett."},{"key":"13744_CR61","doi-asserted-by":"publisher","unstructured":"Cavalli, E. et al. Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? Molecules 25, doi:https:\/\/doi.org\/10.3390\/molecules25051194 (2020).","DOI":"10.3390\/molecules25051194"},{"key":"13744_CR62","doi-asserted-by":"publisher","unstructured":"Cavalli, E. et al. Overexpression of macrophage migration inhibitory factor and its homologue D-dopachrome tautomerase as negative prognostic factor in neuroblastoma. Brain Sci 9, doi:https:\/\/doi.org\/10.3390\/brainsci9100284 (2019).","DOI":"10.3390\/brainsci9100284"},{"key":"13744_CR63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/jb\/mvv091","volume":"159","author":"M Ida","year":"2016","unstructured":"Ida, M. et al. Structural basis of Cu, Zn-superoxide dismutase amyloid fibril formation involves interaction of multiple peptide core regions. J. Biochem. 159, 247\u2013260. https:\/\/doi.org\/10.1093\/jb\/mvv091 (2016).","journal-title":"J. Biochem."},{"key":"13744_CR64","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1073\/pnas.1320786110","volume":"111","author":"MI Ivanova","year":"2014","unstructured":"Ivanova, M. I. et al. Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS. Proc. Natl. Acad Sci. USA 111, 197\u2013201. https:\/\/doi.org\/10.1073\/pnas.1320786110 (2014).","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"13744_CR65","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1039\/c4mt00278d","volume":"7","author":"SS Leal","year":"2015","unstructured":"Leal, S. S., Cristovao, J. S., Biesemeier, A., Cardoso, I. & Gomes, C. M. Aberrant zinc binding to immature conformers of metal-free copper-zinc superoxide dismutase triggers amorphous aggregation. Metallomics 7, 333\u2013346. https:\/\/doi.org\/10.1039\/c4mt00278d (2015).","journal-title":"Metallomics"},{"key":"13744_CR66","doi-asserted-by":"publisher","first-page":"20913","DOI":"10.1073\/pnas.1218792109","volume":"109","author":"C Liu","year":"2012","unstructured":"Liu, C. et al. Out-of-register beta-sheets suggest a pathway to toxic amyloid aggregates. Proc. Natl. Acad Sci. USA 109, 20913\u201320918. https:\/\/doi.org\/10.1073\/pnas.1218792109 (2012).","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"13744_CR67","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nn.4272","volume":"19","author":"YJ Zhang","year":"2016","unstructured":"Zhang, Y. J. et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat. Neurosci. 19, 668\u2013677. https:\/\/doi.org\/10.1038\/nn.4272 (2016).","journal-title":"Nat. Neurosci."},{"key":"13744_CR68","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.bbapap.2015.01.014","volume":"426\u2013436","author":"NK Bhatia","year":"1854","unstructured":"Bhatia, N. K. et al. Curcumin binds to the pre-fibrillar aggregates of Cu\/Zn superoxide dismutase (SOD1) and alters its amyloidogenic pathway resulting in reduced cytotoxicity. Biochim. Biophys. Acta 426\u2013436, 2015. https:\/\/doi.org\/10.1016\/j.bbapap.2015.01.014 (1854).","journal-title":"Biochim. Biophys. Acta"},{"key":"13744_CR69","doi-asserted-by":"publisher","first-page":"26581","DOI":"10.1074\/jbc.M110.113951","volume":"285","author":"H Ouertatani-Sakouhi","year":"2010","unstructured":"Ouertatani-Sakouhi, H. et al. Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action. J. Biol. Chem. 285, 26581\u201326598. https:\/\/doi.org\/10.1074\/jbc.M110.113951 (2010).","journal-title":"J. Biol. Chem."},{"key":"13744_CR70","doi-asserted-by":"publisher","first-page":"10994","DOI":"10.1073\/pnas.1221817110","volume":"110","author":"C Fan","year":"2013","unstructured":"Fan, C. et al. MIF intersubunit disulfide mutant antagonist supports activation of CD74 by endogenous MIF trimer at physiologic concentrations. Proc. Natl. Acad. Sci. U S A 110, 10994\u201310999. https:\/\/doi.org\/10.1073\/pnas.1221817110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"13744_CR71","doi-asserted-by":"publisher","unstructured":"Sugimoto, H. et al. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution. Biochemistry 38, 3268\u20133279, doi:https:\/\/doi.org\/10.1021\/bi982184o (1999).","DOI":"10.1021\/bi982184o"},{"key":"13744_CR72","doi-asserted-by":"publisher","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1\u2013222, doi:https:\/\/doi.org\/10.1080\/15548627.2015.1100356 (2016).","DOI":"10.1080\/15548627.2015.1100356"},{"key":"13744_CR73","doi-asserted-by":"publisher","first-page":"10826","DOI":"10.1038\/s41598-019-47326-x","volume":"9","author":"S Bakavayev","year":"2019","unstructured":"Bakavayev, S. et al. Cu\/Zn-superoxide dismutase and wild-type like fALS SOD1 mutants produce cytotoxic quantities of H2O2 via cysteine-dependent redox short-circuit. Sci. Rep. 9, 10826. https:\/\/doi.org\/10.1038\/s41598-019-47326-x (2019).","journal-title":"Sci. Rep."},{"key":"13744_CR74","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1021\/acschemneuro.6b00227","volume":"7","author":"V Banerjee","year":"2016","unstructured":"Banerjee, V. et al. Superoxide dismutase 1 (SOD1)-derived peptide inhibits amyloid aggregation of familial amyotrophic lateral sclerosis SOD1 mutants. ACS Chem. Neurosci. 7, 1595\u20131606. https:\/\/doi.org\/10.1021\/acschemneuro.6b00227 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"13744_CR75","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.4049\/jimmunol.181.4.2330","volume":"181","author":"AM Coleman","year":"2008","unstructured":"Coleman, A. M. et al. Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog D-dopachrome tautomerase. J. Immunol. 181, 2330\u20132337. https:\/\/doi.org\/10.4049\/jimmunol.181.4.2330 (2008).","journal-title":"J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13744-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13744-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13744-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:09:40Z","timestamp":1669349380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13744-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13744"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13744-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"1 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9570"}}